ACETAZOLAMIDE ER 500 MG CAP

Acetazolamide Extended-Release
$0.2866per EA

Strength

500 mg/1

Manufacturer

AvPAK

NDC

50268004212

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ACETAZOLAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207401

On Market Since

7/20/2022

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors
Sulfonamides

Price History

1W

0.0%

1M

-1.3%

3M

-6.2%

6M

+8.0%

1Y

-9.3%

3Y

-18.5%

5Y

N/A

All

-19.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.